HiringIndustry InsightsTelemedicineUS

Telehealth in 2026: The Regulation, Reimbursement and Retention Hiring Trifecta

By July 31, 2026August 13th, 2026No Comments6 min read

Telehealth came out of the pandemic with real momentum. Regulatory flexibilities unlocked new prescribing models, reimbursement parity gave companies a commercial foundation to build on, and consumer adoption jumped years ahead of where it would have been otherwise. For a while, the hiring challenge was simply keeping up with growth.

2026 is a different picture. The flexibilities that drove the expansion are being replaced by a permanent framework that’s more demanding. Reimbursement parity is under pressure in several payer categories. And the talent that Telehealth companies hired quickly during the growth phase is now being competed for by a broader digital health market that’s matured around them.

Three forces are shaping the hiring environment simultaneously: regulation, reimbursement, and retention. For Telehealth People leaders and CEOs thinking about talent strategy over the next 12 to 18 months, understanding each of them matters.

Force 1: Regulation

The DEA’s telemedicine prescribing framework is the most consequential regulatory development for Telehealth talent teams right now. The temporary flexibilities that allowed controlled substance prescribing via telemedicine without an in-person evaluation are being replaced by a permanent framework that’s more restrictive, more complex to navigate, and more dependent on clinical compliance expertise than the pandemic-era rules it’s replacing.

For Telehealth companies in mental health, addiction medicine, pain management, or any area where controlled substance prescribing is central to the clinical model, this is an immediate hiring priority. Compliance, clinical operations, and regulatory affairs functions need people who specifically understand the new DEA framework, not just telemedicine compliance in general.

The roles this is driving include clinical compliance managers with DEA telemedicine experience, regulatory affairs leads who can manage the company’s relationship with the DEA and state medical boards at the same time, and clinical operations leaders who can redesign prescribing workflows around the new requirements without degrading the patient experience that differentiates Telehealth from traditional care.

These aren’t easy profiles to find. The number of compliance and regulatory affairs professionals with direct experience of the DEA telemedicine framework as it currently stands is small because the framework itself is recent. Companies that move quickly here will have a real advantage over those that wait.

Beyond the DEA, state-level regulation continues to add complexity. Interstate medical licensure, varying state telehealth practice standards, and differing rules around audio-only telemedicine all require ongoing regulatory and compliance resource that most Telehealth companies are underinvesting in relative to the actual risk.

Force 2: Reimbursement

Reimbursement parity for Telehealth has been one of the most contested policy questions in US healthcare over the past three years. Extensions of pandemic-era Medicare telehealth flexibilities have provided temporary stability, but the longer-term picture remains uncertain – particularly for audio-only visits, behavioral health services, and remote patient monitoring.

For talent teams, reimbursement uncertainty creates a specific hiring challenge: the commercial and finance functions need people who can model and manage a revenue base that’s partly dependent on policy decisions outside the company’s control.

The roles most directly affected are health economics and outcomes research leads who can build the clinical evidence base that supports reimbursement arguments with payers, market access specialists who understand the Medicare and Medicaid landscape for digital health services, and VP-level commercial leaders who have navigated payer relationships in an environment where contract terms are actively being renegotiated.

At a strategic level, reimbursement pressure is also accelerating the shift toward value-based care models. Companies that can demonstrate clinical outcomes and cost savings are better positioned with payers and health systems than those still selling on access and convenience alone. That shift is creating demand for a new kind of senior hire: leaders who can build and articulate the value-based care case, combining clinical evidence, health economics, and commercial strategy. These people are rare and in high demand across digital health right now.

Force 3: Retention

The rapid hiring Telehealth companies did during the growth phase created teams that are now being tested by a harder operating environment. Slower growth, regulatory complexity, and reimbursement uncertainty have changed the day-to-day reality for many employees – and the retention risk is real.

The functions most at risk are the ones with the most options elsewhere. Clinical product managers, health data scientists, and senior engineers are being actively recruited by health systems, health insurance technology companies, and Big Tech platforms with serious digital health ambitions. Mission-driven culture is still a genuine retention asset, but it’s not enough on its own against materially better compensation from larger organizations.

The challenge is sharpest at VP and director level. Senior leaders who joined during the growth phase with equity packages tied to high valuations are in some cases holding paper that’s declined significantly. Reduced equity upside combined with a more demanding operating environment creates real flight risk at exactly the level of seniority where turnover is most disruptive.

The companies managing retention best right now are doing a few things. They’re having honest conversations with senior team members about equity and the realistic path to value creation. They’re investing in the development of high-potential leaders rather than assuming mission alignment will hold them. And they’re benchmarking compensation against the broader HealthTech market regularly, not against internal bands that were set when the Telehealth talent market looked very different.

Why These Three Forces Interact

Regulation, reimbursement, and retention don’t operate in isolation. They compound each other in ways that make this a genuinely difficult environment to navigate.

Regulatory change creates urgent hiring needs that compete for budget with the retention investment that’s simultaneously required. Reimbursement uncertainty makes headcount planning harder, which in turn makes it harder to build the talent pipeline the regulatory environment demands. And retention pressure at senior level means the leaders best placed to navigate the regulatory and reimbursement challenges are also the ones most at risk of leaving.

Talent teams that manage this well are the ones that prioritize clearly, move quickly on urgent mandates, and treat retention as a proactive strategy rather than a reactive one.

How Storm3 Supports Telehealth Hiring

Storm3’s Telehealth recruitment team works with virtual care and digital health companies across clinical, commercial, and technology functions. Our connections into Digital Health Insurance recruitment and the broader HealthTech landscape give us reach into the adjacent talent pools that Telehealth companies increasingly need. As executive search becomes a more central part of how we work with clients, we’re building specific capability around the VP and C-suite mandates that the current Telehealth environment is making urgent.

Have a Telehealth hiring mandate? Submit your vacancy and our team will be in touch.

We’ve helped some of the most successful HealthTech startups grow.

— now it’s your turn.

Share